The PIK3CA/AKT pathway drives therapy resistance in rhabdomyosarcoma.
PIK3CA/AKT通路驱动横纹肌肉瘤的治疗耐药性。
期刊:Nature Communications
影响因子:15.7
doi:10.1038/s41467-025-66632-9
Yang Qiqi, Wang Yueyang, Corchete Sanchez Luis A, Mathavarajah Sabateeshan, Qin Qian, Wei Yun, Alpert Eric, Whelton Lauren, Sharma Priyanshu, Strom Stephanie, Oultache Ilyas, Iafrate A John, Pinello Luca, Rheinbay Esther, Yan Chuan, Langenau David M